News

Phase 3 trial shows Botox Cosmetic significantly improved appearance of moderate to severe neck bands compared to placebo in adults.

New data shows cardiovascular improvements from GLP-1 medications may reverse within weeks of stopping treatment, raising concerns about long-term care.

New MOF-based system delivers antimicrobial peptides and irisin sequentially to fight gum disease and promote tissue healing.

New market analysis forecasts robust growth in aesthetic neurotoxins through 2034, driven by mainstream acceptance and younger demographics.

New review outlines how mesenchymal stem cell exosomes could treat heart disease through multiple pathways and targeted delivery methods.

New research shows hormone replacement therapy may help menopausal women lose weight and maintain stronger bones during this transition.

UCHealth clarifies hormone therapy benefits and risks for menopause, addressing confusion from decades of mixed medical messaging.

GLP-1 medications have normalized injectable therapies, creating consumer openness to emerging peptide-based wellness treatments.

FDA enforcement on compounded peptides creates uncertainty for physicians and patients amid safety and regulatory compliance concerns.

Stopping Ozempic and similar GLP-1 drugs may reverse heart-protective benefits, raising cardiovascular risk for patients.